IRCT2017051923559N13尚未招募1 期
Survey Efficacy of the fibrinogen and Fresh frozen plasma in the hemodynamic and clinical outcomes of patients with severe trauma
Vice chancellor for research, Shahid Beheshti University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age over 18 years old; patients with multiple trauma; need for repeated transfusion; injury severity score 16 and above; satisfaction to participate in the study. Exclusion criteria: Unwillingness of the patient to continue cooperation in the plan; trauma limited to head; Penetrating trauma; injury severity score less than 16.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Effect of fibrinogen compared to fresh frozen plasma on patients with hemorrhagic shockIRCT20150704023046N4Ahvaz University of Medical Sciences30
进行中（未招募）
不适用
Efficacy and safety of Fibrinogen Concentrate (Human) for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiency - NDCongenital fibrinogen deficiency ( afibrinogenemia, severe hypofibrinogenemia)MedDRA version: 9.1Level: LLTClassification code 10016075EUCTR2007-004088-22-ITCSL BEHRING GmbH23
进行中（未招募）
不适用
Efficacy and safety of Fibrinogen Concentrate (Human) for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiencyFibrinogen Concentrate (Human) (FCH) - efficacy and safetyCongenital fibrinogen deficiency (afibrinogenemia, severe hypofibrinogenemia)MedDRA version: 12.0Level: LLTClassification code 10016075Term: Factor I deficiencyEUCTR2007-004088-22-DECSL Behring GmbH23
进行中（未招募）
1 期
Effect of prophylactic fibrinogen concentrate in surgery of abnormal lateral curvature of the spine: A randomized pilot study (EFISS trial)MedDRA version: 20.0Level: PTClassification code 10039727Term: Scoliosis surgerySystem Organ Class: 10042613 - Surgical and medical proceduresScoliosisEUCTR2021-005493-25-CZFakultní nemocnice Brno32
尚未招募
3 期
The administration of fibrinogen concentrate (a component of blood involved in clotting process) to be given to those women who, after delivery of babies, develop severe bleeding to establish if this drug will prevent further blood loss or reduce the volume of blood loss.Post partum haemorrhageReproductive Health and Childbirth - Childbirth and postnatal careBlood - Clotting disordersACTRN12614000691640Auckland City Hospital245